Artiva Biotherapeutics, Inc. ARTV
4.20 USD +0.01 (+0.24%)
At closeNov 3, 2026, 4:00 PM EST
4.20 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
4.16 Day range 4.25
2.96 52-week range 14.53
- YTD
- -2.10%
- 1 year
- +11.41%
Financial health
Altman Z-Score
4.66 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -1.3×
FY 2019 5y median -2.9× FY 2025
P/S 0.0×
FY 2019 5y median 42.8× FY 2025
P/B 1.0×
FY 2019 5y median -1.5× FY 2025
P/FCF -1.3×
FY 2019 5y median -4.4× FY 2025
EV/EBITDA -1.1×
FY 2019 5y median -2.2× FY 2025
EV/Sales 0.0×
FY 2019 5y median 25.9× FY 2025
FCF Yield -75.7%
FY 2019 5y median -22.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median -1213.3% FY 2025
Net Margin 0.0%
FY 2019 5y median -1184.1% FY 2025
ROE -76.3%
FY 2019 5y median 17.1% FY 2025
ROIC -74.9%
FY 2019 5y median -35.3% FY 2025
ROA -64.0%
FY 2019 5y median -42.3% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2019 FY 2025
Operating Income -34.7%
FY 2019 FY 2025
EPS (diluted) 34.0%
FY 2019 FY 2025
Free Cash Flow -42.5%
FY 2019 FY 2025
Financial Health
Current Ratio 8.6×
FY 2019 5y median 8.4× FY 2025
Quick Ratio 8.6×
FY 2019 5y median 8.4× FY 2025
Debt / Equity 0.1×
FY 2019 5y median -0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2019 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31